Neuroleptic malignant syndrome in clinical practices
Topic: Neuroleptic Malignant Syndrome is a rare but specific lethal reaction to neuroleptics / antipsychotics.It occurs in 0.02% to 3.3% of patients in the treatment applying conventional neuroleptic drugs. Neuroleptic malignant syndrome is associated with highly potent antipsychotic drugs. However,...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Srpsko lekarsko drustvo
2016-01-01
|
Series: | Hospital Pharmacology |
Subjects: | |
Online Access: | http://scindeks-clanci.ceon.rs/data/pdf/2334-9492/2016/2334-94921603435B.pdf |